Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04809051
Other study ID # 1 F30 HL152526-01-D
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date August 31, 2023

Study information

Verified date February 2024
Source Carnegie Mellon University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This empirical study tests whether transplant center performance data that reflect center donor acceptance rates influence patients and their family members to evaluate centers with high organ decline rates less favorably than centers with low organ decline rates. 400 transplant patients and family members will be recruited from transplant support group social media websites and randomized to one of four different information presentation conditions. Upon viewing a pair of outcome tables corresponding to their condition, the participants are asked to choose which hospital is higher performing (one hospital with a non-selective "accepting" strategy and one hospital with a more selective "cherrypicking" strategy.


Recruitment information / eligibility

Status Completed
Enrollment 94
Est. completion date August 31, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Participants will be asked to participate if they confirm the following inclusion criteria in the consent form. 1. 18 years of age or older 2. must read and understand the information in the consent form 3. must want to participate in the research and continue with the survey 4. must be a pre- or post-transplant patient or family member of the transplant patient Exclusion Criteria: Participants who do not meet the primary criterion of being a pre- or post-transplant patient or family member of the transplant patient.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Stratified Transplant Survival Metric
Both transplant metric conditions display the number of hearts offered to each center, the number of hearts accepted by each center, and the number of transplants performed at each center (in a year), in addition to the condition-specific metrics below. The stratified condition instead features a pair of values corresponding to each center's offers/acceptances/transplant survival rates for donor hearts of "optimal" or "adequate" quality.
SRTR Information Format
The information format varies based on how the transplant hospital statistics are organized when presented to participants on the choice screen. The SRTR conditions mimic the information format present on the SRTR public reporting website.

Locations

Country Name City State
United States Carnegie Mellon University Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Carnegie Mellon University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hospital Choice The outcome variable will be a measure of binary choice between two hospitals: one with a selective donor-heart acceptance strategy and one with a non-selective donor heart acceptance strategy.
Participants will respond to the question "Which Hospital is higher performing? Please click on one of the two tables below to indicate which hospital is the better choice." Participants will choose been two outcome tables featuring the selective and non-selective hospital (counterbalanced, such that each of the two choices is equally likely to be presented at top of the choice scenario in each condition). The number of participants that choose each hospital will be the measured outcome variable used in analyses.
1 day
Secondary Mediator of Hospital Choice On the next page of the survey, participants will respond to three mediator questions: "There are many reasons why one transplant hospital might outperform another. Which reasons were most important in your decision? Please move the slider to indicate how much you considered each of the reasons below (0=reason was not important, 100=reason was extremely important)."
Participants will then move a slider bar (0-100) to indicate the importance of the following three items:
Patients were more likely to receive an excellent donor heart at the hospital I picked.
Patients were less likely to receive a marginal donor heart at the hospital I picked.
Patients were more likely to receive any kind of heart at the hospital I picked.
The third item (more likely to receive any kind of heart) will be the only variable that is included in the planned mediation analysis.
1 day
See also
  Status Clinical Trial Phase
Completed NCT04176796 - Don't Throw Your Heart Away: Medical Student Study 2 N/A
Completed NCT04133831 - Don't Throw Your Heart Away: Layperson Study 1 N/A
Completed NCT04455893 - Don't Throw Your Heart Away: Clinician Study 3 N/A
Recruiting NCT02670408 - Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Completed NCT03393793 - HEart trAnsplantation Registry of piTie-Salpetriere University Hospital
Completed NCT01760538 - Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training N/A
Withdrawn NCT03026023 - Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant Phase 4